Brief: Protagenic Therapeutics Inc - Expects To Commence Clinical Trials In Q4 Of 2022
02/09/2022 22:36
Sept 2 (Reuters) - Protagenic Therapeutics Inc PTIX.O :
* PROTAGENIC THERAPEUTICS INC - EXPECTS TO COMMENCE CLINICAL
TRIALS IN Q4 OF 2022
* PROTAGENIC THERAPEUTICS INC - ONAUGUST 30, CO RECEIVED CMC
QUESTIONS FROM EUROPEAN REGULATORY AUTHORITY REQUIRING A
RESPONSE
* PROTAGENIC THERAPEUTICS INC - IN ADDITION, COMPANY IS
FINALIZING
ITS U.S. SUBMISSION
Further company coverage: PTIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln